Clearside Biomedical Inc.
13F holders, Q2 2025 (June 30)45holders +1
6new positions
5sold out
1famous investor
$0.80avg. 13F price*
At the end of Q2 2025, 45 institutions reported holding Clearside Biomedical Inc. in their 13F filings, up 1 from Q1 2025. 6 opened new positions and 5 sold out. The largest holders were Vanguard Group Inc. ($2.7M), Carmignac Gestion ($1.2M) and Geode Capital Management, LLC ($632K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Clearside Biomedical Inc.
- CUSIP
- 185063104
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $15K |
| Exits | 5 | $73K |
All 13F filers, Q1 2025 → Q2 2025: 981,680 shares bought and 408,056 shares sold, net +573,624 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 45 holders
| Vanguard Group Inc. | 0.00% | Add +19.8% | 3,363,061 | $2.7M |
| Carmignac Gestion | 0.02% | No change | 1,508,342 | $1.2M |
| Geode Capital Management, LLC | 0.00% | Reduce -0.2% | 790,373 | $632K |
| BlackRock, Inc. | 0.00% | Reduce -21.9% | 625,187 | $500K |
| Gsa Capital Partners LLP | 0.03% | Add +164.7% | 533,524 | $427K |
| Renaissance Technologies | 0.00% | Reduce -10.4% | 496,589 | $397K |
| First Manhattan Co. Llc. | 0.00% | No change | 342,725 | $274K |
| State Street Corp. | 0.00% | No change | 265,263 | $212K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -19.6% | 205,000 | $164K |
| Northern Trust Corp. | 0.00% | No change | 165,499 | $132K |
| Assenagon Asset Management S.A. | 0.00% | No change | 131,913 | $106K |
| Morgan Stanley | 0.00% | No change | 130,896 | $105K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 107,919 | $86K |
| Brown Wealth Management, LLC | 0.02% | No change | 100,000 | $80K |
| Northeast Financial Consultants Inc | 0.00% | No change | 93,000 | $74K |
| Susquehanna International Group, LLP | 0.00% | Add +170.2% | 89,620 | $72K |
| Captrust Financial Advisors | 0.00% | No change | 87,000 | $70K |
| Stifel Financial Corp. | 0.00% | Add +66.8% | 39,944 | $32K |
| Investor's Fiduciary Advisor Network, LLC | 0.01% | No change | 33,800 | $27K |
| UBS Group AG | 0.00% | Reduce -47.6% | 32,513 | $26K |
| Newman Dignan & Sheerar, Inc. | 0.01% | No change | 30,123 | $24K |
| Synovus Financial Corp. | 0.00% | No change | 30,000 | $24K |
| PKS Advisory Services, LLC | 0.00% | No change | 24,500 | $20K |
| Westmount Partners, LLC | 0.01% | No change | 23,400 | $19K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 22,500 | $18K |
| Mariner, LLC | 0.00% | No change | 18,950 | $15K |
| Waverly Advisors, LLC | 0.00% | No change | 18,380 | $15K |
| Oppenheimer & Co. Inc. | 0.00% | No change | 14,341 | $11K |
| Stratos Wealth Advisors, LLC | 0.00% | No change | 14,000 | $11K |
| Gen-Wealth Partners Inc | 0.00% | New | 10,000 | $8K |
| Rockwood Wealth Management, LLC | 0.00% | No change | 10,000 | $8K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | No change | 10,500 | $8K |
| Wells Fargo & Company | 0.00% | New | 6,000 | $5K |
| Osaic Holdings, Inc. | 0.00% | Add +170.5% | 2,705 | $2K |
| Bank of America Corp. | 0.00% | Add +13.8% | 2,167 | $2K |
| Royal Bank of Canada | 0.00% | New | 1,400 | $1K |
| CIBC Private Wealth Group LLC | 0.00% | No change | 1,100 | $880 |
| Raymond James Financial Inc. | 0.00% | New | 999 | $799 |
| JPMorgan Chase & Co. | 0.00% | Reduce -91.6% | 840 | $672 |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -83.5% | 810 | $648 |
| SBI Securities Co., Ltd. | 0.00% | Add +61.2% | 782 | $626 |
| Creative Financial Designs Inc. | 0.00% | No change | 100 | $80 |
| Allworth Financial LP | 0.00% | New | 50 | $40 |
| BNP Paribas Financial Markets | 0.00% | No change | 2 | $2 |
| Simplex Trading, LLC | 0.00% | New | 127 | $0 |
"% of holder's portfolio" is CLEARSIDE BIOMEDICAL INC's weight in each manager's 13F, not the share of Clearside Biomedical Inc. the manager owns.